Gedera, Israel

Konstantin Adamsky

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 3.5

ph-index = 1


Company Filing History:


Years Active: 2019-2021

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Konstantin Adamsky

Introduction

Konstantin Adamsky is a notable inventor based in Gedera, Israel. He has made significant contributions to the field of medical science, particularly in the development of compositions for treating various neurological conditions. With a total of seven patents to his name, Adamsky's work is recognized for its potential impact on healthcare.

Latest Patents

Among his latest patents, Adamsky has developed compositions comprising triterpenoids aimed at treating optic neuropathy. This invention focuses on formulations that include at least one triterpenoic acid and one neutral triterpenoid, showcasing their therapeutic potential for optic neuropathy conditions. Additionally, he has created compositions for treating Alzheimer's disease, Parkinson's disease, and vascular dementia, further emphasizing the versatility of triterpenoids in addressing critical health issues.

Career Highlights

Adamsky's career is marked by his dedication to innovation in the pharmaceutical field. His work at Regenera Pharma Ltd. has positioned him as a key player in the development of new treatments that leverage the properties of triterpenoids. His research not only contributes to scientific knowledge but also aims to improve patient outcomes in neurodegenerative diseases.

Collaborations

Throughout his career, Adamsky has collaborated with esteemed colleagues such as Zadik Hazan and Andre C B Lucassen. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to groundbreaking advancements in medical treatments.

Conclusion

Konstantin Adamsky's contributions to the field of medicine through his innovative patents and collaborative efforts highlight his commitment to improving healthcare. His work continues to pave the way for new therapeutic options for patients suffering from neurological conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…